311 related articles for article (PubMed ID: 28458141)
1. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.
Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T
J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141
[TBL] [Abstract][Full Text] [Related]
2. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review.
Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T
Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382
[TBL] [Abstract][Full Text] [Related]
3. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.
Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS
J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613
[TBL] [Abstract][Full Text] [Related]
4. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
[TBL] [Abstract][Full Text] [Related]
5. Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.
Vares EA; Lehmann S; Sauer C; Pariante C; Wieland F; Soltmann B; Bauer M; Ritter P
J Affect Disord; 2020 Dec; 277():450-455. PubMed ID: 32871531
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
[TBL] [Abstract][Full Text] [Related]
7. Targeting the immune system in the treatment of bipolar disorder.
Rosenblat JD
Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
[TBL] [Abstract][Full Text] [Related]
8. Bipolar Disorder and Inflammation.
Rosenblat JD; McIntyre RS
Psychiatr Clin North Am; 2016 Mar; 39(1):125-37. PubMed ID: 26876323
[TBL] [Abstract][Full Text] [Related]
9. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder.
Maes M; Carvalho AF
Mol Neurobiol; 2018 Dec; 55(12):8885-8903. PubMed ID: 29611101
[TBL] [Abstract][Full Text] [Related]
10. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.
Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF
Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835
[TBL] [Abstract][Full Text] [Related]
12. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder.
Bond DJ; Andreazza AC; Hughes J; Dhanoa T; Torres IJ; Kozicky JM; Young LT; Lam RW; Yatham LN
Psychoneuroendocrinology; 2016 Mar; 65():76-83. PubMed ID: 26731572
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder.
Kok Kendirlioglu B; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Cihnioglu R; Kalelioglu T; Ilnem MC; Karamustafalioglu N
Nord J Psychiatry; 2020 Feb; 74(2):83-88. PubMed ID: 31575320
[No Abstract] [Full Text] [Related]
14. Inflammatory mediators of cognitive impairment in bipolar disorder.
Bauer IE; Pascoe MC; Wollenhaupt-Aguiar B; Kapczinski F; Soares JC
J Psychiatr Res; 2014 Sep; 56():18-27. PubMed ID: 24862657
[TBL] [Abstract][Full Text] [Related]
15. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls.
García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J
Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS
Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.
Amerio A; Odone A; Liapis CC; Ghaemi SN
Acta Psychiatr Scand; 2014 May; 129(5):343-58. PubMed ID: 24506190
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.
Rowland T; Perry BI; Upthegrove R; Barnes N; Chatterjee J; Gallacher D; Marwaha S
Br J Psychiatry; 2018 Sep; 213(3):514-525. PubMed ID: 30113291
[TBL] [Abstract][Full Text] [Related]
20. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
